Expression profiling of genes in androgen metabolism in androgen-independent prostate cancer cells under an androgen-deprived environment: mechanisms of castration resistance

نویسندگان

  • Wu Zhou
  • Yan Jiang
  • Lili Ji
  • Lianlian Zhou
  • Meijuan Zhang
  • Mo Shen
  • Jia Zhao
  • Hongxiang Tu
  • Zhongyong Wang
  • Ruihao Wu
  • Yuehui Chen
  • Cui Zhou
  • Kate Huang
  • Zhihua Tao
چکیده

Objective: In an earlier study, we obtained androgen-independent prostate cancer cells (LNCaP-AI) and flutamide tolerantLNCaP-AI (LNCaP-AI+F cells) that could survive in an androgen-free environment without or with flutamide, respectively. In the present study, we investigated the molecular mechanism of the castration resistance. Material and Methods: qRT-PCR was applied to measure the expression levels of genes coding for enzymes in the lysophosphatidylcholine (LPC) metabolic pathway and responsible for cholesterol and androgen metabolism in these cell lines. An ExProfileTM Human PI3K-AKT Signaling Related Gene qPCR Array was also used to investigate the expression levels of genes in the intracellular metabolic pathways in an emasculated hormone environment. Results: Compared with androgen-responsive prostate cancer (LNCaP) cells, phospholipase D1 (PLD1) expression was increased 259and 410-folds in LNCaP-AI and LNCaP-AI+F cells, respectively, and the PI3K/AKT signaling pathway was enhanced. Additionally, the expression of cholesterol metabolic enzymes and rate-limiting enzymes, such as organic anion-transporting polypeptide 1B3 (OATP1B3) (LNCaP-AI cells: 19.08-fold; LNCaP-AI+F cells: 14.34-fold), low density lipoprotein receptor (LDL-r ) (LNCaP-AI cells: 23.34-fold; LNCaP-AI+F cells: 8.78-fold), squalene epoxidase (SQLE) (LNCaP-AI cells: 22.03-fold; LNCaP-AI+F cells: 10.27-fold), and scavenger receptor B1 (SCARB1) (LNCaP-AI cells: 10.27-fold; LNCaP-AI+F cells: 5.75-fold), was significantly increased. Furthermore, the expression of androgen synthetases, such as steroid 17-alpha-monooxygenase (CYP17A1) (LNCaP-AI cells: 28.59-fold; LNCaP-AI+F cells: 4.32-fold), steroid 5 alpha-reductase 2 (SRD5A2) (LNCaP-AI cells: 51.50-fold; LNCaP-AI+F cells: 12.91-fold), aldo-keto reductases (AKR1C1, AKR1C2, AKR1C3) (LNCaP-AI: 8.63-fold; LNCaP-AI+F cells: 7.10-fold), and androgen receptor (AR) (LNCaP-AI: 39.18-fold; LNCaP-AI+F cells: 36.56-fold), was increased significantly (P < 0.05). Conclusions: Our results revealed that the survival of LNCaP AI cells in androgen-free medium is due to selfsynthesis of androgen, increased cholesterol intake and increased AR expression. These evidences suggest that the castration-resistant LNCaP cells are not androgen-independent but have developed or activated a set of AR-related signaling pathways to increase endogenous androgen biosynthesis and AR expression.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Role of WNT7B-induced noncanonical pathway in advanced prostate cancer.

Advanced prostate cancer is characterized by incurable castration-resistant progression and osteoblastic bone metastasis. While androgen deprivation therapy remains the primary treatment for advanced prostate cancer, resistance inevitably develops. Importantly, mounting evidence indicates that androgen receptor (AR) signaling continues to play a critical role in the growth of advanced prostate ...

متن کامل

Chromatin, Gene, and RNA Regulation Role of WNT7B-induced Noncanonical Pathway in Advanced Prostate Cancer

Advanced prostate cancer is characterized by incurable castration-resistant progression and osteoblastic bone metastasis. While androgen deprivation therapy remains the primary treatment for advanced prostate cancer, resistance inevitably develops. Importantly, mounting evidence indicates that androgen receptor (AR) signaling continues to play a critical role in the growth of advanced prostate ...

متن کامل

Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions

The androgen receptor (AR) is a ligand-inducible transcription factor that mediates androgen action in target tissues. Upon ligand binding, the AR binds to thousands of genomic loci and activates a cell-type specific gene program. Prostate cancer growth and progression depend on androgen-induced AR signaling. Treatment of advanced prostate cancer through medical or surgical castration leads to ...

متن کامل

Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy

  Background: Prostate cancer is one of the leading causes of cancer deaths among men. New gene expressed in prostate (NGEP), is a prostate-specific gene expressed only in normal prostate and prostate cancer tissue. Because of its selective expression in prostate cancer cell surface, NGEP is a potential immunotherapeutic target. To target the NGEP in prostate cancer, it is essential to investig...

متن کامل

Progression Model Progression in a Lineage-Derived Prostate Cancer and Signaling Are Components of Androgen-Independent Increased Insulin-Like Growth Factor I Receptor Expression

Apoptosis and inhibition of mitosis are primary mechanisms mediating androgen ablation therapy-induced regression of prostate cancer (PCa). However, PCa readily becomes androgen independent, leading to fatal disease. Up-regulated growth and survival signaling is implicated in development of resistance to androgen ablation therapy. We are testing the hypothesis that insulin-like growth factor (I...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2016